Article
Pharmacogenetic impact of UGT1A1 polymorphisms on pulmonary neuroendocrine tumours treated with metronomic irinotecan-based chemotherapy in Chinese populations.
The Journal of pharmacy and pharmacology - 1 Nov 2020
Ma Xu, Han Sen, Liu Ying, Liu Jing-Tao, Fang Jian, Zhang Yan-Hua
Abstract excerpt
OBJECTIVES: To evaluate the effects of UGT1A1*6 and UGT1A1*28 polymorphisms on the safety and efficacy of metronomic irinotecan-based chemotherapy (IBC) in Chinese patients with pulmonary neuroendocrine tumours (PNTs). METHODS: Sixty-eight PNT patients who received metronomic IBC were observed. The quantitative fluorescent polymerase chain reaction was used to detect UGT1A1*6 and UGT1A1*28 polymorphisms. The...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
